Some small business owners allegedly lost as much as $250,000

By Truman Lewis of ConsumerAffairs

• Agency crackdown: FTC accuses Air AI of luring entrepreneurs with false promises of business growth, big earnings, and guaranteed refunds.

• High losses reported: Some small business owners allegedly lost as much as $250,000, often ending up in debt.

• Court action: FTC seeks to halt Air AIs practices, alleging violations of consumer protection and telemarketing rules.

The Federal Trade Commission has filed a complaint against Delaware-based Air AI Technologies, alleging the company and its operators misled small business owners with false promises of huge profits, refund guarantees, and cutting-edge AI services that rarely delivered.

According to the FTC, Air AI and its owners Caleb Matthew Maddix, Ryan Paul ODonnell, and Thomas Matthew Lancer marketed their conversational AI technology as a replacement for human customer service and as a tool that would generate tens of thousands of dollars, or even millions, for business owners. Since early 2023, the company allegedly sold business coaching programs, licenses, and an Air AI Access Card under the promise of fast returns and risk-free investments.

Unrealistic promises and broken guarantees

The FTC alleges that many entrepreneurs who bought into Air AIs offerings lost large sums of money, with some losing up to $250,000. Despite marketing refund guarantees promising to repay two to three times the customers investment if they failed to earn profits the company rarely honored those commitments, the complaint states. Instead, customers often faced delays, poor communication, and ultimately no refund.

Companies that market AI-related tools with false promises of unrealistic investment returns and guaranteed refunds harm hardworking small business owners and undermine legitimate businesss adoption of AI, said Christopher Mufarrige, director of the FTCs Bureau of Consumer Protection.

Alleged rule violations

The Commissions complaint accuses Air AI and five affiliated companies of violating multiple consumer protection laws, including:

• Making false or unsubstantiated claims about likely earnings.

• Misrepresenting refund policies and product performance.

• Violating the Telemarketing Sales Rule and Business Opportunity Rule by failing to provide required disclosure documents, exaggerating profitability, and refusing refunds.

The FTC is asking a federal court to halt the practices and provide relief for affected consumers.

Low expectations index may signal a looming recession

By Truman Lewis of ConsumerAffairs

• Index edges lower: The Conference Board Consumer Confidence Indexfell 1.3 points in August to 97.4, as views on jobs and incomes weakened.

• Recession signal: Expectations Index stayed below 80, a threshold that often signals a looming recession.

• Inflation concerns: Write-in responses showed growing worries about tariffs, high prices, and rising inflation expectations.

U.S. consumer confidence slipped modestly in August as concerns about job prospects and household income outweighed more optimistic views of business conditions, according to new data from The Conference Board.

The Consumer Confidence Index fell to 97.4 this month, down from 98.7 in July. The Present Situation Index, reflecting consumers view of current business and labor market conditions, dropped to 131.2. The Expectations Index, which tracks the short-term outlook for income, jobs, and business conditions, fell to 74.8remaining under the level of 80 that often foreshadows a recession.

Labor market concerns mount

Consumer confidence dipped slightly in August but remained at a level similar to those of the past three months, said Stephanie Guichard, senior economist at The Conference Board. She noted that consumers appraisal of job availability declined for the eighth straight month, even as assessments of current business conditions improved.

Expectations for the labor market also weakened. Nearly 27% of respondents said they expect fewer jobs to be available in the next six months, up from 25% in July. Optimism about future income also slipped, with fewer consumers expecting raises and more anticipating declines.

Inflation expectations rise again

Consumers reported growing concerns about prices, particularly food and groceries, as mentions of inflation and tariffs increased in survey responses. Average 12-month inflation expectations rose to 6.2% in August from 5.7% in July, reversing three months of easing.

Confidence levels varied across demographics: sentiment fell among those under 35, held steady for people 35 to 55, and improved among those over 55. By political affiliation, confidence weakened for Republicans and Democrats but was little changed for Independents.

Spending intentions mixed

Purchasing plans shifted in August, with buying intentions for both new and used cars rising, while intentions for TVs and tablets fell. Consumers plans to travel, dine out, and spend on entertainment also softened. Non-discretionary spending plans, such as for financial services and home or car maintenance, improved slightly.

The survey, based on an online sample conducted by Toluna, closed August 20.

How a molecular sponge engineered from a bacterial sensor could save lives in minutes

• Rapid CO removal: The engineered protein RcoM-HBD-CCC clears half of the carbon monoxide in blood in under a minute far faster than pure oxygen therapy.

• Selective and safe: It binds CO without disturbing oxygen or critical signaling molecules like nitric oxide, minimizing blood pressure risks.

• Promising pre-clinical results: In mouse studies, it cleared CO quickly and was safely excreted in urine, paving the way for future human trials.

Carbon monoxide (CO), a colorless and odorless danger, binds to our bloods hemoglobin up to 400 times more strongly than oxygen, choking off vital oxygen supply.

Currently, treatments like breathing pure oxygen sometimes under high pressure can take over an hour to clear CO. And even then, nearly half of survivors risk long-term heart or brain damage.

Researchers from the University of Maryland School of Medicine and the University of Pittsburgh have now developed a fresh approach: a specially engineered protein dubbed RcoM-HBD-CCC, which is designed to act like a sponge that soaks up CO from the blood with lightning speed.

Unlike other protein-based treatments, we found the compound caused only minimal changes in blood pressure, which was an exciting finding and raised the potential for this new molecule to have clinical applications, study author Mark T. Gladwin, M.D., said in a news release.

This has the potential to become a rapid, intravenous antidote for carbon monoxide that could be given in the emergency department or even in the field by first-responders.

How the researchers engineered the protein

The team started with RcoM, a natural protein that bacteria use to sense tiny amounts of CO in their surroundings.

They fine-tuned it to create RcoM-HBD-CCC a highly selective protein for CO over oxygen, and avoiding interference with oxygen transport.

Using a technique called stopped-flow electronic absorption spectroscopy, they measured how quickly it binds: RcoM-HBD-CCC grabs CO nearly 50 times faster than hemoglobin does.

A critical issue with similar protein therapies has been their tendency to bind nitric oxide (NO), a molecule that helps regulate blood pressure causing dangerous spikes when NO is depleted.

However, in tests with mice, RcoM-HBD-CCC caused no significant changes in blood pressure, suggesting a much safer profile.

The results

In mouse experiments, RcoM-HBD-CCC cleared half of the CO from the bloodstream in less than a minute a dramatic improvement compared to the hour-plus required under pure oxygen therapy, and several hours with no treatment at all.

After binding CO, the protein-CO complex was safely eliminated via urine, showing a smooth exit route and low risk of buildup.

Whats next? Further trials to refine dosage, safety, and effectiveness then, hopefully, human clinical trials.

This novel protein might not only become the first actual antidote for CO poisoning, but potentially a basis for new ways to deliver oxygen or assist in critical conditions like severe anemia or organ preservation.

This molecule could be a game-changer because it can directly and rapidly remove carbon monoxide from the body with such a low risk of off-target side effects, researcher Jason J. Rose, M.D., said in the news release.

Given the promising results, we also see the potential for RcoM-HBD-CCC use in other areas, like as a blood substitute in severe anemia or hemorrhagic shock.

Two lots of frozen dog and cat food being recalled

Viva Raw LLC of Charlotte, N.C., is recalling two lots of frozen dog and cat foods after testing detected contamination with Salmonella and Listeria monocytogenes.

The recall covers products from Lot 21495 and Lot 21975, which were distributed nationwide between July 2 and August 21, 2025, through direct-to-consumer sales and select retailers in New York, Illinois, South Carolina, Florida, Kansas, California, and Arizona.

Products affected

• Lot 21495: Viva Ground Beef for Dogs; Viva Beef & Turkey for Puppies

• Lot 21975: Viva Ground Chicken for Dogs; Viva Chunked Chicken for Dogs; Viva Chicken for Cats; Viva Pure Chicken

The products were sold as frozen 1-pound bricks in clear vacuum packaging with the lot number printed on top.

Health risks for people and pets

Salmonella and Listeria can sicken both pets and humans. People handling contaminated pet food are at risk if they do not thoroughly wash their hands or clean surfaces after contact.

In people, symptoms may include nausea, vomiting, diarrhea, abdominal cramping, and fever. In rare cases, infections can become more serious, leading to arterial infections, arthritis, or miscarriage in pregnant women.

Pets infected with Salmonella or Listeria may show signs such as lethargy, diarrhea, vomiting, fever, or abdominal pain. Even pets that appear healthy can shed the bacteria and infect other animals or humans.

No illnesses reported so far

The potential contamination was identified through routine testing by the North Carolina Department of Agriculture. To date, no illnesses in people, dogs, or cats have been reported in connection with the recalled products.

What consumers should do

Consumers who purchased these lots should:

• Stop feeding the recalled food to pets.

• Contact Viva Raw at info@vivarawpets.com or (919) 371-8882 for a refund.

• Dispose of recalled food safely, where children, pets, and wildlife cannot access it.

• Clean and sanitize all pet bowls, cups, utensils, and storage containers that may have come into contact with the food.

• Wash hands thoroughly after handling recalled products or anything they touched.

Viva Raw said only Lots 21495 and 21975 are affected by the recall.